Patent details
300994
Product Name:
Apremilast of een farmaceutisch aanvaardbaar zout daarvan
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300994
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2962690
Status:
SPC in force
Application number:
300994
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)
Marketing Authorization
Marketing Authorization Number:
EU/1/14/981
Marketing Authorization Type:
EEA
Marketing Authorization Date:
16/01/2015
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
18/06/2019
First Marketing Authorization date:
16/01/2015
Grant date:
11/07/2019
Activation date:
20/03/2023
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
21/06/2019
SPC/SPC Extension Expiration Date:
19/03/2028
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
29/06/2020
Name:
Amgen (Europe) GmbH
Address:
Floor 6-8 Suurstoffi 22, 6343, Risch-Rotkreuz, Switzerland (CH)
Historical Applicant/holder
From:
18/06/2019
To:
29/06/2020
Name:
Celgene Corporation
Address:
86 Morris Avenue, SUMMIT, NJ 07901, United States of America (US)
Agent
Name:
ir. H.A. Witmans c.s.
From:
18/06/2019
Address:
V.O.
Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
SPC
Journal edition number:
12/23
Publication date:
22/03/2023
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
2
Bulletin Heading:
CO
Journal edition number:
29/20
Publication date:
14/08/2020
Description:
Changes in the Netherlands Patent Register
3
Bulletin Heading:
SPC
Journal edition number:
29/19
Publication date:
17/07/2019
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
Bulletin Heading:
SPC
Journal edition number:
26/19
Publication date:
26/06/2019
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC202001217A
Date Registered:
29/06/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
Amgen (Europe) GmbH
Address:
Floor 6-8 Suurstoffi 22, 6343, Risch-Rotkreuz, Switzerland (CH)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Other
Note:
Annual Fee
Annual Fee(s) Due Date:
31/03/2026
Annual Fee Number:
24
Annual Fee Amount:
2200 Euro
Last Annual Payment Date:
19/02/2025
Last Annual Fee Paid Number:
23
Last Annual Fee Paid Amount:
2000 Euro
Payer:
Anaqua Services
Filing date
Document type
Document Description
Number of pages
File Type
30/07/2019
SPC Documents
Certificate SPC
1
PDF
/1/2/5/5/2/0800425521/docs/300994_8_supplprotectioncertificate20190730024918293.pdf
11/07/2019
Outgoing Correspondence
Decision grant
1
PDF
/1/2/5/5/2/0800425521/docs/300994_4_outgoingcorrespondence20190712090755195.pdf
24/06/2019
Outgoing Correspondence
Confirmation receipt request
1
PDF
/1/2/5/5/2/0800425521/docs/300994_6_281710l174.pdf
18/06/2019
SPC Documents
Accompanying letter SPC
2
PDF
/1/2/5/5/2/0800425521/docs/300994_0_supplprotectioncertificate20210122032951255.pdf
18/06/2019
SPC Documents
Annex SPC
2
PDF
/1/2/5/5/2/0800425521/docs/300994_1_supplprotectioncertificate20190621113230771.pdf
18/06/2019
SPC Documents
Summary of the characteristics of the product
34
PDF
/1/2/5/5/2/0800425521/docs/300994_2_supplprotectioncertificate20190621113230527.pdf
18/06/2019
SPC Documents
Annex SPC
2
PDF
/1/2/5/5/2/0800425521/docs/300994_3_supplprotectioncertificate20190621113230602.pdf
18/06/2019
Application Form
First filed application form
3
PDF
/1/2/5/5/2/0800425521/docs/300994_5_applicationform20190621113230193.pdf
18/06/2019
SPC Documents
Annex SPC
15
PDF
/1/2/5/5/2/0800425521/docs/300994_7_supplprotectioncertificate20190621113230668.pdf
18/06/2019
SPC Documents
Marketing Authorization SPC
3
PDF
/1/2/5/5/2/0800425521/docs/300994_9_supplprotectioncertificate20190621113230370.pdf